Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 4/30/15  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Michael L. Kranda

Wrong Michael L. Kranda?

Chief Executive Officer

Local Address: Seattle, Washington, United States
Company Description: BEAT BioTherapeutics Corp. (BEATBio) is developing BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. Heart...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • MBA
  • BA , finance
    University of Washington
161 Total References
Web References
PTC Therapeutics: Board of Directors
www.ptcbio.com, 30 April 2015 [cached]
Michael Kranda
Michael Kranda has served as a member of PTC's board of directors since December 2003. Since September 2006, Mr. Kranda has served as a consultant to Vulcan Capital, the private investment group of Vulcan Inc., and Mr. Kranda served as Managing Director of biotechnology venture investments at Vulcan Capital from September 2003 to September 2006. From July 1996 to July 2002, Mr. Kranda served as Chief Executive Officer at Oxford GlycoSciences, a biotechnology company. Prior to joining Oxford GlycoSciences, Mr. Kranda was President and Chief Operating Officer at Immunex Corporation (now Amgen), a biopharmaceutical company.
...
Mr. Kranda currently serves as Chief Executive Officer and a director of BEAT BioTherapeutics Corporation, a gene therapy company. Mr. Kranda received a B.A. and an M.B.A from the University of Washington School of Business.
Team | BEAT BioTherapeutics
beatbiotherapeutics.com, 31 Jan 2015 [cached]
Michael Kranda, MBA - Chief Executive Officer - Mr. Kranda has over 25 years of biotech operating, finance and corporate development experience. Most recently Mr. Kranda was CEO of Vaccinogen, a cancer vaccine company. Mr. Kranda served as Managing Director of Vulcan Capital for several years, where he led all aspects of their Life Sciences investment efforts. Mr. Kranda was also the CEO of Oxford GlycoSciences, a pioneer in proteomic based drug and diagnostic product development.
...
Mr. Kranda started his biotech career at Immunex Corporation where he served as President, COO and Director and is currently a Director for PTC Therapeutics, Inc. (NASDAQ: PTCT).
...
Michael Kranda - Chief Executive Officer.
BEATBio Board of Directors | BEAT BioTherapeutics
beatbiotherapeutics.com, 31 Jan 2015 [cached]
Michael Kranda | Chief Executive Officer
Mr. Kranda has over 25 years of biotech operating, finance and corporate development experience. Most recently Mr. Kranda was CEO and a director of Vaccinogen, a cancer vaccine company. Mr. Kranda served as Managing Director of Vulcan Capital (Paul Allen's investment vehicle) for several years, where he led all aspects of their Life Sciences investment efforts and continues to serve as a consultant. Mr. Kranda was also the CEO of Oxford GlycoSciences, a pioneer in proteomic based drug and diagnostic product development.
...
Prior to joining Oxford GlycoSciences, Mr. Kranda was President, COO and director at Immunex Corporation (now Amgen) and is currently a Director for PTC Therapeutics, Inc. (NASDAQ: PTCT) and Chairman of the Audit Committee.
Healthcare Sales & Marketing Network: Medical Device and Pharmaceutical News (HSMN NewsFeed)
salesandmarketingnetwork.com, 1 June 2008 [cached]
Anesiva Names Michael L. Kranda as President, Chief Executive Officer and Member of Its Board of Directors
Anesiva - Media
ansv.client.shareholder.com [cached]
SOUTH SAN FRANCISCO, Calif., Aug 29, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced that Michael L. Kranda, the company's president and chief executive officer, will present at BioCentury's Newsmakers in the Biotech Industry Conference in New York City on September 4, 2008 at 2:00 p.m. ET. To... Read more
...
Anesiva Names Michael L. Kranda as President, Chief Executive Officer and Member of Its Board of Directors Jun 16, 2008 PDF 11.1 KB Add to Briefcase
SOUTH SAN FRANCISCO, Calif., June 16, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced the appointment of Michael L. Kranda as president, chief executive officer and a member of the company's board of directors, effective June 16, 2008. Mr. Kranda succeeds John P. McLaughlin, who resigned as chief ...
Other People with the name "Kranda":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304